Effects of testosterone on norepinephrine release in isolated rat heart

Abstract

The effects of testosterone on norepinephrine release were investigated in the isolated rat hearts. Sprague-Dawley male rats (n=120) were randomized to testosterone and control groups. The rats in testosterone group were perfused with modified Krebs-Henseleit buffer containing different concentrations of testosterone (0.1, 1.0, 10.0, and 100.0 nmol/L, respectively). Myocardial ischemia was induced by globally stopping the perfusion flow. Exocytotic norepinephrine release was induced by electrical field stimulation at 5 V (effective voltage) and 6 Hz (pulse width of 2 ms) for 1 min. The overflow of norepinephrine was determined by high pressure liquid chromatography and electrochemical detection (HPLC-EC). Following acute ischemia, testosterone (1.0, 10.0 and 100.0 nmol/L) significantly reduced norepinephrine release (P<0.01), and the norepinepherine overflow was similar between the control and 0.1 nmol/L testosterone group (P>0.05). Electrical stimulation of the ventricle evoked norepinepherine release, and this was diminished by the perfusion with testosterone at the concentrations of 1.0, 10.0 and 100.0 nmol/L (P<0.01). It is suggested that testosterone suppresses ischemia- and electrical stimulation-induced norepinepherine release in the isolated rat hearts.

Keywords

testosterone / ischemia-reperfusion / norepinephrine / ventricular fibrillation

References

[1] KurzT., OffnerB., SchreieckJ., et al.. Nonexocytotic noradrenaline release and ventricular fibrillation in ischemic rat hearts. Naunyn Schmiedebergs Arch Pharmacol, 1995, 352(5): 491-496

[2] KontoleonP.E., Anastasiou-NanaM.I., PapapetrouP.D., et al.. Hormonal profile in patients with congestive heart failure. Int J Cardiol, 2003, 287(2–3): 179-183

[3] MalkinC.J., PughP.J., JonesR.D., et al.. The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men. J Clin Endocrinol Metab, 2004, 89(7): 3313-3318

[4] MalkinC.J., PughP.J., MorrisP.D., et al.. Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life. Heart, 2004, 90(8): 871-876

[5] KangS.M., JangY., KimJ.Y., et al.. Effect of oral administration of testosterone on brachial arterial vasoreactivity in men with coronary artery disease. Am J Cardiol, 2002, 89(7): 862-864

[6] ShapiroJ., ChristianaJ., FrishmanW.H.. Testosterone and other anabolic steroids as cardiovascular drugs. Am J Ther, 1999, 6(3): 167-174

[7] MalkinC.J., PughP.J., WestJ.N., et al.. Testosterone therapy in men with moderate severity heart failure: a double-blind randomized placebo controlled trial. Eur Heart J, 2006, 27(1): 57-64

[8] PughP.J., JonesT.H., ChannerK.S.. Acute haemodynamic effects of testosterone in men with chronic heart failure. Eur Heart J, 2003, 24(10): 909-915

[9] ZhangY.Z., XingX.W., HeB., et al.. Effects of testosterone on cytokines and left ventricular remodeling following heart failure. Cell Physiol Biochem, 2007, 20(6): 847-852

[10] WalkerM.J., CurtisM.J., HearseD.J., et al.. The Lambeth conventions: guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion. Cardiovasc Res, 1988, 22(7): 447-455

[11] SeyfarthM., FengY., HaglS., et al.. Effect of myocardial ischemia on stimulation-evoked noradrenaline release modulated neurotransmission in rat, guinea pig, and human cardiac tissue. Circ Res, 1993, 73(3): 496-502

[12] SeyfarthM., RichardtG., MizsnyakA., et al.. Transient ischemia reduces norepinephrine release during sustained ischemia. Neural preconditioning in isolated rat heart. Circ Res, 1996, 78(4): 573-80

[13] ZhuW.Z., WangS.Q., ChakirK., et al.. Linkage of beta1-adrenergic stimulation to apoptotic heart cell death through protein kinase A-independent activation of Ca²⁺/calmodulin kinase II. J Ciin Invest, 2003, 111(5): 617-625

[14] QinF., ShiteJ., LiangC.S.. Antioxidants attenuate myocyte apoptosis and improve cardiac function in CHF: association with changes in MAPK pathways. Am J Physiol Heart Circ Physiol, 2003, 285(2): H822-H832

[15] SchömigA.. Catecholamines in myocardial ischemia. Systemic and cardiac release. Circulation, 1990, 82(3Suppl): II13-H22

[16] RemondinoA., KwonS.H., CommunalC., et al.. Beta-adrenergic receptor-stimulated apoptosis in cardiac myocytes is mediated by reactive oxygen species/c-Jun NH2-terminal kinase-dependent activation of the mitochondrial pathway. Circ Res, 2003, 92(2): 136-138

[17] KurzT., RichardtG., HaglS., et al.. Two different mechanisms of noradrenaline release during normoxia and simulated ischemia in human cardiac tissue. J Mol Cell Cardiol, 1995, 7(5): 161-172

[18] KurzT., RichardtD., GörgeB., et al.. Differential effects of carvedilol on norepinephrine release in normoxic and ischemic heart. Cardiovasc Pharmacol, 2000, 36(1): 96-100

[19] KaplinskyE., OgawaS., MichelsonE.L., et al.. Instantaneous and delayed ventricular arrhythmias after reperfusion of acutely ischemic myocardium: evidence for multiple mechanisms. Circulation, 1981, 63: 333-340